XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCK-BASED COMPENSATION (Tables)
 3 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options
The following table summarizes the activity relating to the Company’s market-based stock options for the three-month period ended June 30, 2024:
OptionsWeighted-
Average
Exercise Price 		Weighted Average Contractual Remaining Term (years)Aggregate Intrinsic Values (in thousands)*
Outstanding as of April 1, 20245,445 13.39 — — 
Granted— — — — 
Exercised— — — — 
Forfeited— — — — 
Outstanding as of June 30, 20245,445 13.397.72$1,488 
Vested as of June 30, 2024— — — $— 
The following table summarizes the activity relating to the Company’s stock options, excluding the market-based stock options, for the three-month period ended June 30, 2024:

OptionsWeighted-
Average
Exercise Price		Weighted Average Contractual Remaining Term (years)Aggregate Intrinsic Values (in thousands)*
Outstanding as of April 1, 20241,979 4.68 — — 
Granted375 4.31 — — 
Exercised— — — — 
Forfeited(6)6.10 — — 
Outstanding as of June 30, 20242,348 4.627.2$779 
Vested as of June 30, 20241,973 4.67 6.6$779 
Schedule of Fair Value Valuation Assumptions
The fair value of each option grant on the date of grant is estimated using the Black-Scholes option-pricing model reflecting the following weighted-average assumptions:

June 30, 2023June 30, 2024
Expected volatility 55.6 %60.2 %
Expected life of options6.16.5
Risk free interest rate3.87 %4.23 %
Dividend yield— — 
Weighted-average fair value of options granted during the year$1.66$2.66
Schedule of Restricted Stock Activity A summary of all non-vested restricted stock for the three-month period ended June 30, 2024 is as follows:
Number of
Non-Vested Shares
Weighted- Average
Grant Date Fair Value
Non-vested, March 31, 20241,370 2.68 
Granted54 5.45 
Vested(1,369)2.68 
Forfeited or expired— — 
Non-vested, June 30, 202455 2.68 
Schedule of Unvested SARs Activities
The following table summarizes the activities for the outstanding SARs:
Number of SARsWeighted-
Average
Exercise Price		Weighted Average Contractual Remaining Term (years)Aggregate Intrinsic Values (in thousands)*
Outstanding as of April 1, 2024— — 
Acquired through MiX Combination5,740 2.61 
Granted— — 
Exercised— — 
Forfeited— — 
Outstanding as of June 30, 20245,740 2.613.33
Vested as of June 30, 20241,813 2.98 1.80$2,881